Trial Profile
Effect of bortezomib when administered subcutaneously in combination with melphalan and prednisone in patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 22 May 2015 New trial record